Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. - Wikidata - wikimedia - TriplyDB

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

http://www.wikidata.org/entity/Q33438663

about

Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment Gene-expression patterns predict phenotypes of immune-mediated thrombosis The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin Thrombophilia and pregnancy The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.A case of cerebral infarction associated with positive antiphospholipid antibody in a systemic lupus patient.Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?Controversies in lupus: nervous system involvement.Testing for and clinical significance of anticardiolipin antibodies Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient-A High Suspicion Is Still Needed Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians The lung in the antiphospholipid syndrome.Lupus: an overview of the disease and management options.Antiphospholipid syndrome: an overview.Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?Retinal disease in patients with systemic lupus erythematosus Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures.Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.Thrombosis in systemic lupus erythematosus: a French collaborative study Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.Antiphospholipid syndrome: multiple mechanisms.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis.Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.Thrombophilia in a man with long-standing hypogonadism.Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome.Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.

P2860

Q24675466-4F46CE43-7C6C-4204-BE54-F73DFFC41C4A Q24685918-F490A218-A276-4286-95F8-2A8778ED3A97 Q24798707-11180169-81D0-4735-8BD0-3DCEF928216B Q24801115-1113722B-30FE-4E68-8EC7-43520EC987D2 Q28379106-95161E36-1807-4879-A7AB-8CF9726D1564 Q33363443-CFFDE4DE-655F-4647-8227-144D21A692DE Q33491733-0FD212BB-78BB-4F4B-A934-036E964CFB41 Q33499900-DBDC0E11-631B-4E55-8D3B-3B742531EF7E Q33566129-E0D22D80-C45A-4799-9708-0A027170115D Q33567067-D2F182AA-4C48-4524-97E5-68C5CC173391 Q33766710-134F1246-C3CC-42BB-9459-937974FDC112 Q33768066-316FAE2D-C759-4F35-9A45-90E11F43FDAF Q33832953-21FE517A-B743-4FC8-9E12-D58C356D0DD3 Q34400681-F090D833-00EE-440A-966D-9CAF649DB7B7 Q34519511-07856461-5F62-4F7E-AF0F-99DABBA3520A Q34638296-29D400E3-0180-47D1-8146-068303B484C2 Q35099505-81D207C1-9769-441D-BCA2-E5BAED40BF53 Q35549358-87530A61-8B89-4F96-9204-0F13F9B73017 Q35549623-21F10A7E-6F02-42F5-9FDC-B85A73F93349 Q35553271-4BA073F0-A3E0-4601-8E0D-2FE6EF49486B Q35554870-4A51E7C6-980C-47C5-A13D-8C85BED64D85 Q35555112-4C9F9821-102D-4D52-81A2-2CE2A7AAEFD8 Q35626838-57095392-E6C3-4843-A2BA-A8691640EB62 Q35709692-2B654005-BFA3-4058-88D9-5D8F85E86A2F Q35775322-79F582C5-5D01-408B-97D7-830E369418AF Q35849691-52B420E0-057C-47B1-AF93-FC8C09875068 Q35998510-2761FA67-9C92-40DD-91A6-0CB9DABC43AF Q36387401-78A941DF-DFD3-4E28-A383-174F99FC1B34 Q36440223-46DE42C8-80E4-47AA-8A54-CDD4A7AD6F4C Q36625369-A1CDCE4F-684B-4C74-BA24-4CDE777E0C08 Q36728278-40152DB1-3258-4538-88FE-4D30F79C62C0 Q36751188-D1ED50C8-4345-419B-9F0D-D2354E353D21 Q37045158-909C6DFC-FDC4-4A83-B3BF-94C7570E3665 Q37358421-FEC1D93E-C195-4E2E-BD03-53B80056C4ED Q41818166-380BA747-97EA-4714-B6DF-508D1176C016 Q49072554-ECDD3684-E09A-4D6F-9BEE-67990F038335

P2860

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

http://www.wikidata.org/entity/Q33438663

description

1989 nî lūn-bûn

@nan

1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@ast

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@en

type

label

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@ast

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@en

prefLabel

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@ast

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@en

P1433

Q33438663-AA148D20-20E1-4D0A-8B27-BFF8FE3022BA

P1476

Q33438663-016CB9F3-9BDB-42E7-9067-C750C71A3D3E

P2093

Q33438663-1C7CFDD5-F639-44A0-9742-AAAC8BB4AD7B

Q33438663-2D2831BF-EAA1-44CA-8015-3C088413E992

Q33438663-328B64BB-EFDA-40FE-9457-3E739D2E5713

Q33438663-47C32C3E-6D5C-47E5-B593-4C3370B42C1A

Q33438663-A22E1656-4AE5-45EF-936B-4FAE8388097A

Q33438663-D7C38370-3292-4253-9C79-A1DBB32AB3CA

Q33438663-DAD80CE3-74B7-4655-B3DF-2D4DF688F1D0

Q33438663-DD85B943-881C-40E7-9501-C2F88C653A83

P304

Q33438663-E70C8A07-8C32-415F-BAF5-2C29DFB71296

P31

Q33438663-9ABD6E87-6927-4343-8963-7A395CF11C9C

P407

Q33438663-97AD7506-7319-4047-BB47-FCDCD078CFB0

P433

Q33438663-B529AEF1-BAF3-405E-BFD0-5C31DFC40C8D

P478

Q33438663-2ADBBF17-6C0B-472B-9E34-731D37482015

P577

Q33438663-D8D3F486-99CA-4FBD-B11B-DD2E64155839

P698

Q33438663-C84A524F-038F-4879-B2C2-D0F2BA051362

P921

Q33438663-2195DC38-1D1F-4C78-9323-77ECA6CA374F

P1433

P1476

Antiphospholipid antibodies an ...... s of 500 consecutive patients.

@en

P2093

Alarcón-Segovia D

http://www.w3.org/2001/XMLSchema#string

Cabiedes J

http://www.w3.org/2001/XMLSchema#string

Delezé M

http://www.w3.org/2001/XMLSchema#string

Fernández L

http://www.w3.org/2001/XMLSchema#string

Gómez-Pacheco L

http://www.w3.org/2001/XMLSchema#string

Oria CV

http://www.w3.org/2001/XMLSchema#string

Ponce de León S

http://www.w3.org/2001/XMLSchema#string

Sánchez-Guerrero J

http://www.w3.org/2001/XMLSchema#string

P304

353-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

1989-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2811661

http://www.w3.org/2001/XMLSchema#string

P921